Cargando…
Whole-exome analysis of 177 pediatric patients with undiagnosed diseases
Recently, whole-exome sequencing (WES) has been used for genetic diagnoses of patients who remain otherwise undiagnosed. WES was performed in 177 Japanese patients with undiagnosed conditions who were referred to the Tokai regional branch of the Initiative on Rare and Undiagnosed Diseases (IRUD) (TO...
Autores principales: | Narita, Kotaro, Muramatsu, Hideki, Narumi, Satoshi, Nakamura, Yuji, Okuno, Yusuke, Suzuki, Kyogo, Hamada, Motoharu, Yamaguchi, Naoya, Suzuki, Atsushi, Nishio, Yosuke, Shiraki, Anna, Yamamori, Ayako, Tsumura, Yusuke, Sawamura, Fumi, Kawaguchi, Masahiro, Wakamatsu, Manabu, Kataoka, Shinsuke, Kato, Kohji, Asada, Hideyuki, Kubota, Tetsuo, Muramatsu, Yukako, Kidokoro, Hiroyuki, Natsume, Jun, Mizuno, Seiji, Nakata, Tomohiko, Inagaki, Hidehito, Ishihara, Naoko, Yonekawa, Takahiro, Okumura, Akihisa, Ogi, Tomoo, Kojima, Seiji, Kaname, Tadashi, Hasegawa, Tomonobu, Saitoh, Shinji, Takahashi, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418234/ https://www.ncbi.nlm.nih.gov/pubmed/36028527 http://dx.doi.org/10.1038/s41598-022-14161-6 |
Ejemplares similares
-
Minor PNH clones do not distinguish inherited bone marrow failure syndromes from immune-mediated aplastic anemia
por: Narita, Atsushi, et al.
Publicado: (2022) -
Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes
por: Miwata, Shunsuke, et al.
Publicado: (2021) -
Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia
por: Kitazawa, Hironobu, et al.
Publicado: (2021) -
Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital
por: Nishida, Yoshihiro, et al.
Publicado: (2021) -
Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
por: Imaya, Masayuki, et al.
Publicado: (2022)